loadpatents
name:-0.059906959533691
name:-0.028616189956665
name:-0.018991947174072
Gao; Changshou Patent Filings

Gao; Changshou

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gao; Changshou.The latest application filed is for "bispecific binding proteins and uses thereof".

Company Profile
17.29.54
  • Gao; Changshou - Gaithersburg MD
  • Gao; Changshou - Potomac MD
  • Gao; Changshou - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods for preparing antibodies with a defined glycosylation pattern
Grant 11,414,477 - Gao , et al. August 16, 2
2022-08-16
Bispecific Binding Proteins And Uses Thereof
App 20220251204 - KASTURIRANGAN; Srinath ;   et al.
2022-08-11
Combination Therapies Using Anti-pseudomonas Psl And Pcrv Binding Molecules
App 20220177554 - DIGIANDOMENICO; Antonio ;   et al.
2022-06-09
Method Of Conjugating A Polypeptide
App 20220160882 - CHRISTIE; Ronald James ;   et al.
2022-05-26
Bispecific binding proteins and uses thereof
Grant 11,279,759 - Kasturirangan , et al. March 22, 2
2022-03-22
Relaxin Fusion Polypeptides And Uses Thereof
App 20220073584 - HAO; Weidong ;   et al.
2022-03-10
Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas perv
Grant 11,203,633 - Digiandomenico , et al. December 21, 2
2021-12-21
Relaxin fusion polypeptides and uses thereof
Grant 11,192,931 - Hao , et al. December 7, 2
2021-12-07
Methods For Preparing Antibodies With A Defined Glycosylation Pattern
App 20210214419 - GAO; CHANGSHOU ;   et al.
2021-07-15
Anti-vegf-a Antibodies And Uses Thereof
App 20210147531 - Leow; Ching Ching ;   et al.
2021-05-20
Neutralizing Anti-influenza Binding Molecules And Uses Thereof
App 20210079069 - KALLEWAARD-LELAY; Nicole ;   et al.
2021-03-18
Conjugated Compounds Comprising Cysteine-engineered Antibodies
App 20210069341 - GAO; Changshou ;   et al.
2021-03-11
Anti-VEGF-A antibodies and uses thereof
Grant 10,919,958 - Leow , et al. February 16, 2
2021-02-16
Anti-vegf-a And Anti-ang2 Antibodies And Uses Thereof
App 20210040194 - Leow; Ching Ching ;   et al.
2021-02-11
Neutralizing anti-influenza binding molecules and uses thereof
Grant 10,882,897 - Kallewaard-Lelay , et al. January 5, 2
2021-01-05
Anti-VEGF-A and anti-ANG2 antibodies and uses thereof
Grant 10,836,819 - Leow , et al. November 17, 2
2020-11-17
Combination Therapies Using Anti-pseudomonas Psl And Pcrv Binding Molecules
App 20200317757 - DIGIANDOMENICO; Antonio ;   et al.
2020-10-08
Conjugated compounds comprising cysteine-engineered antibodies
Grant 10,744,204 - Gao , et al. A
2020-08-18
Method And Molecules
App 20200206359 - Christie; Ronald James ;   et al.
2020-07-02
Bispecific Binding Proteins And Uses Thereof
App 20200172622 - KASTURIRANGAN; SRINATH ;   et al.
2020-06-04
Neutralizing Anti-influenza Binding Molecules And Uses Thereof
App 20200109187 - KALLEWAARD-LELAY; Nicole ;   et al.
2020-04-09
Combination therapies using anti-pseudomonas PSL and PCRV binding molecules
Grant 10,597,439 - Digiandomenico , et al.
2020-03-24
Relaxin Fusion Polypeptides And Uses Thereof
App 20190352366 - HAO; Weidong ;   et al.
2019-11-21
Bispecific binding proteins and uses thereof
Grant 10,457,732 - Kasturirangan , et al. Oc
2019-10-29
Neutralizing anti-influenza binding molecules and uses thereof
Grant 10,442,854 - Kallewaard-Lelay , et al. Oc
2019-10-15
Anti-vegf-a Antibodies And Uses Thereof
App 20190202903 - Leow; Ching Ching ;   et al.
2019-07-04
Anti-vegf-a And Anti-ang2 Antibodies And Uses Thereof
App 20190194308 - Leow; Ching Ching ;   et al.
2019-06-27
Bispecific HER2 antibodies
Grant 10,160,812 - Li , et al. Dec
2018-12-25
Conjugated Compounds Comprising Cysteine-engineered Antibodies
App 20180169255 - Gao; Changshou ;   et al.
2018-06-21
Neutralizing Anti-influenza Binding Molecules And Uses Thereof
App 20180155413 - KALLEWAARD-LELAY; Nicole ;   et al.
2018-06-07
Bispecific Binding Proteins And Uses Thereof
App 20180022807 - KASTURIRANGAN; Srinath ;   et al.
2018-01-25
Method Of Conjugating A Polypeptide
App 20170304460 - CHRISTIE; Ronald James ;   et al.
2017-10-26
Bispecific Her2 Antibodies
App 20170291955 - Li; John ;   et al.
2017-10-12
Cysteine engineered antibodies for site-specific conjugation
App 20170183414 - Dimasi; Nazzareno ;   et al.
2017-06-29
Multi-specific Anti-pseudomonas Psl And Pcrv Binding Molecules And Uses Thereof
App 20170183397 - DIGIANDOMENICO; Antonio ;   et al.
2017-06-29
Multispecific And Multivalent Binding Proteins And Uses Thereof
App 20170114151 - Dimasi; Nazzareno ;   et al.
2017-04-27
Multispecific and multivalent binding proteins and uses thereof
Grant 9,580,509 - Dimasi , et al. February 28, 2
2017-02-28
Cell display of antibody libraries
Grant 9,567,389 - Gao , et al. February 14, 2
2017-02-14
Engineered Fc Regions For Site-Specific Conjugation
App 20160017023 - Dimasi; Nazzareno ;   et al.
2016-01-21
Combination Therapies Using Anti-pseudomonas Psl And Pcrv Binding Molecules
App 20150284450 - Digiandomenico; Antonio ;   et al.
2015-10-08
HSA-related compositions and methods of use
Grant 9,120,875 - Gao , et al. September 1, 2
2015-09-01
HSA-related compositions and methods of use
Grant 9,045,564 - Gao , et al. June 2, 2
2015-06-02
Combination Therapies Using Anti-pseudomonas Psl And Pcrv Binding Molecules
App 20150023966 - Digiandomenico; Antonio ;   et al.
2015-01-22
Multispecific And Multivalent Binding Proteins And Uses Thereof
App 20140302038 - Dimasi; Nazzareno ;   et al.
2014-10-09
Hsa-related Compositions And Methods Of Use
App 20140248682 - GAO; Changshou ;   et al.
2014-09-04
Methods For Making Multimeric Polypeptides
App 20140155581 - Gao; Changshou ;   et al.
2014-06-05
HSA-Related Compositions And Methods Of Use
App 20140148392 - Gao; Changshou ;   et al.
2014-05-29
HSA-related compositions and methods of use
Grant 8,697,650 - Gao , et al. April 15, 2
2014-04-15
Multispecific Epitope Binding Proteins And Uses Thereof
App 20130295098 - Wu; Herren ;   et al.
2013-11-07
Cell Display Of Antibody Libraries
App 20130231463 - GAO; CHANGSHOU ;   et al.
2013-09-05
Mutant antibody Fc domains and fusion proteins thereof
Grant 8,409,568 - Gao , et al. April 2, 2
2013-04-02
Hsa-related Compositions And Methods Of Use
App 20130053322 - Gao; Changshou ;   et al.
2013-02-28
ENGINEERED Fc REGIONS FOR SITE-SPECIFIC CONJUGATION
App 20120213705 - Dimasi; Nazzareno ;   et al.
2012-08-23
High affinity antibodies against HMGB1 and methods of use thereof
Grant 8,153,131 - Wu , et al. April 10, 2
2012-04-10
High affinity antibodies against HMGB1 and methods of use thereof
Grant 8,129,130 - Wu , et al. March 6, 2
2012-03-06
High Affinity Antibodies Against HMGB1 and Methods of Use Thereof
App 20110287023 - Wu; Herren ;   et al.
2011-11-24
Toxin Conjugated Eph Receptor Antibodies
App 20110280892 - Kinch; Michael S. ;   et al.
2011-11-17
High affinity antibodies against HMGB1 and methods of use thereof
Grant 7,964,706 - Wu , et al. June 21, 2
2011-06-21
Antibody Library Display By Yeast Cell Plasma Membrane
App 20110076752 - Wu; Herren ;   et al.
2011-03-31
C/CLP Antagonists And Methods Of Use Thereof
App 20110059100 - Reed; Jennifer L. ;   et al.
2011-03-10
Cysteine Engineered Antibodies For Site-Specific Conjugation
App 20110033378 - Dimasi; Nazzareno ;   et al.
2011-02-10
Cell Display Of Antibody Libraries
App 20100331208 - GAO; Changshou ;   et al.
2010-12-30
Multispecific Epitope Binding Proteins And Uses Thereof
App 20100233173 - WU; Herren ;   et al.
2010-09-16
Cell display of antibody libraries
Grant 7,790,655 - Gao , et al. September 7, 2
2010-09-07
EPH RECEPTOR Fc VARIANTS WITH ENHANCED ANTIBODY DEPENDENT CELL-MEDIATED CYTOTOXICITY ACTIVITY
App 20100203045 - Wu; Herren ;   et al.
2010-08-12
High Affinity Antibodies Against HMGB1 and Methods Of Use Thereof
App 20100061987 - Wu; Herren ;   et al.
2010-03-11
Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity
Grant 7,659,374 - Wu , et al. February 9, 2
2010-02-09
High affinity antibodies against HMGB1 and methods of use thereof
Grant 7,585,504 - Wu , et al. September 8, 2
2009-09-08
High Affinity Antibodies Against Hmgb1 And Methods Of Use Thereof
App 20090169546 - Wu; Herren ;   et al.
2009-07-02
Multispecific Epitope Binding Proteins And Uses Thereof
App 20090155275 - WU; Herren ;   et al.
2009-06-18
Cell display of antibody libraries
App 20070111260 - Gao; Changshou ;   et al.
2007-05-17
Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries
Grant 7,078,166 - Janda , et al. July 18, 2
2006-07-18
High affinity antibodies against HMGB1 and methods of use thereof
App 20060099207 - Wu; Herren ;   et al.
2006-05-11
Ultra high throughput capture lift screening methods
App 20060094062 - Wu; Herren ;   et al.
2006-05-04
EPH receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity
App 20060039904 - Wu; Herren ;   et al.
2006-02-23
Integrin antagonists with enhanced antibody dependent cell-mediated cytoxicity activity
App 20060040325 - Wu; Herren ;   et al.
2006-02-23
Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries
App 20030186322 - Janda, Kim D. ;   et al.
2003-10-02
Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries
Grant 6,472,147 - Janda , et al. October 29, 2
2002-10-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed